We are live on ! Find out more
BC

Bruce & Co Portfolio holdings

AUM $350M
1-Year Est. Return 33.5%
This Fund
S&P 500
This Quarter Est. Return
+6.19%
1 Year Est. Return
+33.5%
3 Year Est. Return
+65.72%
5 Year Est. Return
+73.85%
10 Year Est. Return
+249.08%
AUM
$513M
AUM Growth
+$30.9M
Cap. Flow
-$21.7M
Cap. Flow %
-4.24%
Top 10 Hldgs %
65.73%
Holding
42
New
1
Increased
3
Reduced
7
Closed
–

Top Buys

Rank Stock Value
1
SUPN icon
Supernus Pharmaceuticals
SUPN
+$4.96M
2
GE icon
GE Aerospace
GE
+$4.15M
3
BHC icon
Bausch Health
BHC
+$3.9M
4
FATE icon
Fate Therapeutics
FATE
+$794K

Top Sells

Rank Stock Value
1
AGN
Allergan plc
AGN
+$3.61M
2
IIIN icon
Insteel Industries
IIIN
+$3.44M
3
UHAL icon
U-Haul Holding Co
UHAL
+$2.37M
4
GM icon
General Motors
GM
+$1.82M
5
MNKD icon
MannKind Corp
MNKD
+$1.21M

Sector Composition

Rank Sector Weight
1 Healthcare 30.6%
2 Utilities 28.86%
3 Industrials 12.48%
4 Technology 8.01%
5 Financials 7.2%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MNKD icon
26
MannKind Corp
MNKD
$1.25B
$1.77M 0.35%
1,375,723
-949,056
-41% -$1.21M
VVV icon
27
Valvoline
VVV
$5.1B
$1.47M 0.29%
68,633
– –
FTK icon
28
Flotek Industries
FTK
$947M
$1.42M 0.28%
118,612
-4,167
-3% -$48.1K
PRTK
29
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
$1.07M 0.21%
266,552
– –
FATE icon
30
Fate Therapeutics
FATE
$324M
$978K 0.19%
+50,000
New +$794K
IIIN icon
31
Insteel Industries
IIIN
$602M
$582K 0.11%
27,100
-162,900
-86% -$3.44M
XOM icon
32
ExxonMobil
XOM
$611B
$361K 0.07%
5,184
– –
K
33
DELISTED
Kellanova
K
$306K 0.06%
4,724
– –
XTNT icon
34
Xtant Medical Holdings
XTNT
$63.1M
$292K 0.06%
182,972
– –
XPL icon
35
Solitario Resources
XPL
$69.8M
$76K 0.01%
254,040
– –
1
2

Similar funds

RFS
Retirement Financial Solutions Knoxville, Tennessee $350M AUM 16.94% 1-Year Est. Return
WMP
Wealth Management Partners Tucson, Arizona $350M AUM 39.2% 1-Year Est. Return
PCM
Pennsylvania Capital Management Huntingdon Valley, Pennsylvania $349M AUM 20.19% 1-Year Est. Return
SA
SRH Advisors Salina, Kansas $349M AUM 10.46% 1-Year Est. Return
MC
Merck & Co Kenilworth, New Jersey $349M AUM 146.07% 1-Year Est. Return
KFG
Kingdom Financial Group Peoria, Arizona $349M AUM 12.25% 1-Year Est. Return
LAS
Lloyd Advisory Services Suwanee, Georgia $349M AUM 13.97% 1-Year Est. Return
GAA
Global Assets Advisory Orlando, Florida $349M AUM 24.2% 1-Year Est. Return

Bruce & Co's Q4 2019 Portfolio in Review

As of Q4 2019, Bruce & Co held 42 positions worth $513M, up 6.4% from $482M the previous quarter. Its ten largest holdings account for 66% of the portfolio.

Bruce & Co withdrew a net $21.7M in Q4 2019, reducing 7 holdings. Its largest reduction was Allergan plc, cutting an estimated $3.61M.

By sector, the portfolio is most concentrated in Healthcare at 31% of assets, up from 28% a quarter earlier, followed by Utilities and Industrials.

Against the trend, Bruce & Co opened a new position in Fate Therapeutics worth $978K.

  • Bruce & Co's largest Q4 2019 buy was Fate Therapeutics: 50,000 shares worth $978K.
  • Bruce & Co added most to Supernus Pharmaceuticals in Q4 2019, an estimated $4.96M increase.
  • Bruce & Co's biggest Q4 2019 reduction was Allergan plc, cutting an estimated $3.61M.
  • Bruce & Co's ten largest holdings make up 66% of its $513M portfolio in Q4 2019.
  • Bruce & Co opened 1 new position and closed 0 in Q4 2019.
  • Bruce & Co's portfolio value rose 6.4% quarter-over-quarter to $513M.

Based on Bruce & Co's 13F filing for Q4 2019, filed 14 Feb 2020.